Begin main content


We found 4609 result(s)

Buprenorphine Implant for the Treatment of Opioid Use Disorder

Published on: March 21, 2017
Result type: Reports
opens in document viewer

Summary Probuphine is the first subdermal implant for the maintenance treatment of opioid use disorder designed to provide continuous, non-fluctuating, blood levels of buprenorphine for up to six months following a single outpatient office-based procedure. According to the manufacturer, Probuphine could potentially address issues associated wit...

  • Project Number: EH0044-000


Absorbable Implants, Buprenorphine, Drug Implants, Implants, Probuphine, butrans, implant, sous-cutané, subdermal